Ameritas Advisory Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Ameritas Advisory Services's XPH Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2026: 4,939 shares worth $327K. The stake represents 0.01% of the portfolio and ranks #922 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in XPH as recently as Q2 2025.

Ameritas Advisory Services first reported a position in XPH in Q4 2021 and has held it in 15 quarters since. The position peaked at $661K in Q1 2022. 92 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

• Ameritas Advisory Services held 4,939 shares of State Street SPDR S&P Pharmaceuticals ETF worth $327K as of Q2 2026.
• State Street SPDR S&P Pharmaceuticals ETF was a new Ameritas Advisory Services position in Q2 2026.
• State Street SPDR S&P Pharmaceuticals ETF made up 0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #922 holding.
• Ameritas Advisory Services first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2021 and has held it in 15 quarters since.
• Ameritas Advisory Services's State Street SPDR S&P Pharmaceuticals ETF position peaked at $661K in Q1 2022.
• 92 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.